ERBB2 and cancer: In addition to being an important therapeutic target in individuals with non-small cell lung, breast, and gastroesophageal cancers [10,11], ERBB2 also demonstrated potential as a therapeutic target for other cancers in several randomized clinical trials; ERBB2 status is therefore considered during planning of combination therapy strategies [12,13,14,15].